S.M. Kirov Military medical academy of the Ministry of Defense of the Russian Federation, 194044, St. Petersburg.
Brief summary
Hyperglycemia is often observed in urgent patients hospitalized due to the brain injury, acute ischemic damage to the myocardium and central nervous system, extensive surgical interventions, sepsis development and etc. This transient hyperglycemia is called stress hyperglycemia and can occur in people without a history of diabetes. Relative deficiency of insulin, insulin resistance and activation of gluconeogenesis play an important role in pathogenesis. Mortality and typical complications rates, the length of hospital stay are increased in patients with stress hyperglycemia relative to patients with normal glucose levels. This increased risk is especially high in those without pre-existing diabetes. In the present review, we discuss causes of stress hyperglycemia, the impact on the course of some acute diseases, modern treatment approaches, patient management after discharge from the hospital due to an increased risk of type 2 diabetes.
2. Marik P.E., Bellomo R. Stress hyperglycemia: an essential survival response! Crit. Care. 2013. 17(2):305. https://doi.org/10.1186/cc12514.
3. Mifsud S., Schembri E.L., Gruppetta M. Stress-induced hyperglycaemia. Br J HospMed (Lond). 2018; 79 (11): 634-639. https://doi.org/10.12968/hmed.2018.79.11.634.
4. Yao M., Hao Y., Wang T. et al. A review of stress-induced hyperglycaemia in the context of acute ischaemic stroke: Definition, underlying mechanisms, and the status of insulin therapy. Front. Neurol.2023; 14:1149671. https://doi.org/ 10.3389/fneur.2023.1149671.
5. Harp J.B., Yancopoulos G.D., Gromada J. Glucagon orchestrates stress- induced hyperglycaemia. Diabetes Obes Metab. 2016;18(7):648-53. https://doi.org/ 10.1111/dom.12668.
6. Scheen M., Giraud R., Bendjelid K. Stress hyperglycemia, cardiac glucotoxicity, and critically ill patient outcomes current clinical and pathophysiological evidence. Physiol Rep. 2021;9(2):e14713. https://doi.org/ 10.14814/phy2.14713.
7. Vedantam D., Poman D.S., Motwani L., Asif N., Patel A., Anne K.K. Stress-Induced Hyperglycemia: Consequences and Management. Cureus. 2022;14(7):e26714. https://doi.org/ 10.7759/cureus.26714.
8. Mamtani M., Kulkarni H., Bihari S. et al. Degree of hyperglycemia independently associates with hospital mortality and length of stay in critically ill, nondiabetic patients: results from the ANZICS CORE binational registry. J Crit Care. 2020, 55:149-56. https://doi.org/10.1016/j.jcrc.2019.11.003
9. Sleiman I., Morandi A., Sabatini T., Ranhoff A., Ricci A., Rozzini R., Trabucchi M: Hyperglycemia as a predictor of in-hospital mortality in elderly patients without diabetes mellitus admitted to a sub-intensive care unit. J Am Geriatr Soc. 2008; 56:1106-10. https://doi.org/10.1111/j.1532-5415.2008.01729.x 41.
10. Zhang C., Shen H-C., Liang W-R., et al. Relationship between stress hyperglycemia ratio and allcause mortality in critically ill patients: Results from the MIMIC-IV database. Front. Endocrinol. 2023; 14:1111026. https://doi.org/10.3389/fendo.2023.1111026
11. Tian Y., Wang R., Zhang M, et al. Stress-induced Hyperglycemia Ratio as an Independent Risk Factor of In-hospital Mortality in Nonresuscitation Intensive Care Units: A Retrospective Study. Clin Ther. 2023;45(1):31-39. https://doi.org/10.1016/j.clinthera.2022.12.007.
12. Godinjak A., Iglica A., Burekovic A., et al. Hyperglycemia in Critically Ill Patients: Management and Prognosis. Med Arch. 2015;69(3):157-60. https://doi.org/10.5455/medarh.2015.69.157-160.
13. Jeon C.Y., Furuya E.Y., Berman M.F., Larson E.L. The role of pre- operative and post-operative glucose control in surgical-site infections and mortality. PLoS One. 2012;7(9):e45616. https://doi.org/10.1371/journal.pone.0045616.
14. Biteker M, Dayan A, Can MM, et al. Impaired fasting glucose is associated with increased perioperative cardiovascular event rates in patients undergoing major non-cardiothoracic surgery. Cardiovasc Diabetol. 2011;10:63. https://doi.org/10.1186/1475-2840-10-63.
15. Rajpurohit A., Sejoo B., Bhati R., et al. Association of stress hyperglycemia and adverse cardiac events in acute myocardial infarction - a cohort study. Cardiovasc Hematol Disord Drug Targets. 2021;21:260-265 https://doi.org/10.2174/1871529X22666211221152546.
16. Chen G., Li M., Wen X., et al. Association between stress hyperglycemia ratio and in-hospital outcomes in elderly patients with acute myocardial infarction. Front Cardiovasc Med. 2021;8:698725. https://doi.org/ 10.3389/fcvm.2021.698725.
17. Khalfallah M., Abdelmageed R., Elgendy E., Hafez YM. Incidence, predictors and outcomes of stress hyperglycemia in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. Diab Vasc Dis Res. 2020, 17:13. https://doi.org/10.1177/1479164119883983.
18. Zhu B., Pan Y., Jing J., et al.: Stress hyperglycemia and outcome of non- diabetic patients after acute ischemic stroke. Front Neurol. 2019, 10:1003. https://doi.org/10.3389/fneur.2019.01003.
19. Yuan C, Chen S, Ruan Y, Liu Y, Cheng H, Zeng Y, Chen Y, Cheng Q, Huang G, He W, He J. The Stress Hyperglycemia Ratio is Associated with Hemorrhagic Transformation in Patients with Acute Ischemic Stroke. Clin Interv Aging. 2021;16:431-442. https://doi.org/10.2147/CIA.S280808.
20. Huang Y-W., Yin X-S., Li Z-P. Association of the stress hyperglycemia ratio and clinical outcomes in patients with stroke: A systematic review and meta- analysis. Front. Neurol.2022; 13:999536. https://doi.org/10.3389/fneur.2022.999536.
22. Krukov E.V., Kychmin A.N., Ymanskaya E.P., Nagornii M.B. i soavt. Osnovnie patogeneticheskie mehanizmi giperkoagylyacii pri saharnom diabete i vozmojnosti ee medikamentoznoi korrekcii. Vestnik Rossiiskoi Voenno- medicinskoi akademii. 2021;23(2):165-174. https://doi.org/10.17816/brmma64995.
23. Cigan N.V., Yakovleva V.A., Ryabcev A.V. i dr. Stryktyra i faktori riska posleoperacionnoi mozgovoi disfynkcii v onkohiryrgii. Izvestiya Rossiiskoi Voenno-medicinskoi akademii. 2021; 40(4):43-50. doi: 10.17816/rmmar83621.
24. van den Berghe G., Wouters P., Weekers F. et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001; 345: 1359-1367. https://doi.org/10.1056/NEJMoa011300.
25. Haga KK, McClymont K.L. et al. The effect of tight glycaemic control, during and after cardiac surgery, on patient mortality and morbidity: A systematic review and meta-analysis. Journal of Cardiothoracic Surgery. 2011; 6(1):3. https://doi.org/10.1186/1749-8090-6-3.
26. Finfer S. Clinical controversies in the management of critically ill patients with severe sepsis: resuscitation fluids and glucose control. Virulence. 2014;5(1):200-5. https://doi.org/10.4161/viru.25855.
27. Kyzmich V.G., Halimov U.Sh., Lyanginen T.V. Intensifikaciya insylinoterapii pri sepsise. Sbornik tezisov VIII (XXVI) Nacionalnogo kongressa endokrinologov s mejdynarodnim ychastiem "Personalizirovannaya medicina i prakticheskoe zdravoohranenie". Moskva; 2019: 227-228.
28. Heidary Z, Khalili H, Mohammadi M, Beigmohammadi MT, Abdollahi A Effect of magnesium loading dose on insulin resistance in patients with stress- induced hyperglycemia: a randomized clinical trial. J Intensive Care Med.2020;35:687-693 https://doi.org/10.1177/0885066618777431.